Answers are grounded in this paper and cite their sources.
Dear Editor, Hemorrhage from trauma remains a leading cause of death worldwide. Resuscitative endovascular balloon occlusion of the aorta (REBOA) and emergency department resuscitative thoracotomy (EDRT) are two different aorto-occlusive interventions with dissimilar indications; however, both are aimed at arresting ongoing life-threatening hemorrhage to maintain critical organ perfusion. Conflicting evidence behind their utility still exists, and precise clinical indications for each technique have not been agreed upon.[1,2] Mortality rates vary in the literature, with most studies reporting a survival of 50%–70% following REBOA and <10% following EDRT.[1] There is limited published data from institutions within Australia regarding their use and outcomes. The local environment in Australia is unique in its vast geographic distances, use of aeromedical retrieval services, and pattern of injuries; overseas data may, therefore, not be comparable. To add to the body of evidence underlying REBOA and EDRT use, we carried out a retrospective analysis of the Western Australia (WA) State Trauma Registry database between January 2012 and September 2022. Within the 10,058 patients in the database, 75 EDRT and 11 REBOA procedures were carried out. All were done at our institution. Mean ages were similar between the EDRT and REBOA groups (mean ± standard deviation [SD]: 42 ± 18 vs. 40 ± 19 years, respectively). In the EDRT group, 40% of injuries were due to a penetrating mechanism, whereas all the REBOA patients had a blunt mechanism of injury. Median injury severity score (ISS) was 50 in the REBOA group and 30 in the EDRT group. The mortality following REBOA (4/11, 36%) was lower than that reported in most international studies, despite a higher median ISS in the study population. The mortality following EDRT (74/75, 99%) was slightly worse compared to international data, with similar baseline ISS scores as in these studies. Biochemical trends and transfusion requirements in the REBOA and EDRT groups were also aligned with other studies: REBOA and EDRT patients had an initial lactate of 7.3 ± 3.0 and 13.0 ± 5.7, respectively, and a peak lactate level of 9.8 ± 4.6 and 16.8 ± 10.9, respectively. The REBOA group in this study had an improved survival compared to most published overseas data.[1] This may be due to earlier and technically quicker REBOA placement, shorter inflation time, or differing patient selection leading to indication bias. This is speculation, and the exact reason cannot be identified. The long-term mortality at our institution following EDRT is similar or slightly worse compared to that of other international data.[1,3,4] This is likely a reflection of the maximally invasive nature of this procedure and the increased time taken to reach the level 1 trauma center of WA. In conclusion, we have found an improved survival in our study following REBOA and similar or slightly worse outcomes following EDRT compared to other published data. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Maghami et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: